240 related articles for article (PubMed ID: 32390638)
1. Alzheimer's Disease-Like Neurodegeneration in Porphyromonas gingivalis Infected Neurons with Persistent Expression of Active Gingipains.
Haditsch U; Roth T; Rodriguez L; Hancock S; Cecere T; Nguyen M; Arastu-Kapur S; Broce S; Raha D; Lynch CC; Holsinger LJ; Dominy SS; Ermini F
J Alzheimers Dis; 2020; 75(4):1361-1376. PubMed ID: 32390638
[TBL] [Abstract][Full Text] [Related]
2.
Dominy SS; Lynch C; Ermini F; Benedyk M; Marczyk A; Konradi A; Nguyen M; Haditsch U; Raha D; Griffin C; Holsinger LJ; Arastu-Kapur S; Kaba S; Lee A; Ryder MI; Potempa B; Mydel P; Hellvard A; Adamowicz K; Hasturk H; Walker GD; Reynolds EC; Faull RLM; Curtis MA; Dragunow M; Potempa J
Sci Adv; 2019 Jan; 5(1):eaau3333. PubMed ID: 30746447
[No Abstract] [Full Text] [Related]
3. Microglial Cathepsin B and
Nakanishi H; Nonaka S; Wu Z
CNS Neurol Disord Drug Targets; 2020; 19(7):495-502. PubMed ID: 32640970
[TBL] [Abstract][Full Text] [Related]
4. Secreted gingipains from Porphyromonas gingivalis induce microglia migration through endosomal signaling by protease-activated receptor 2.
Nonaka S; Nakanishi H
Neurochem Int; 2020 Nov; 140():104840. PubMed ID: 32858090
[TBL] [Abstract][Full Text] [Related]
5. Porphyromonas gingivalis and Alzheimer disease: Recent findings and potential therapies.
Ryder MI
J Periodontol; 2020 Oct; 91 Suppl 1(Suppl 1):S45-S49. PubMed ID: 32533852
[TBL] [Abstract][Full Text] [Related]
6. Type IX secretion system is pivotal for expression of gingipain-associated virulence of Porphyromonas gingivalis.
Benedyk M; Marczyk A; Chruścicka B
Mol Oral Microbiol; 2019 Dec; 34(6):237-244. PubMed ID: 31432617
[TBL] [Abstract][Full Text] [Related]
7. The Distinct Immune-Stimulatory Capacities of Porphyromonas gingivalis Strains 381 and ATCC 33277 Are Determined by the
Coats SR; Kantrong N; To TT; Jain S; Genco CA; McLean JS; Darveau RP
Infect Immun; 2019 Dec; 87(12):. PubMed ID: 31570556
[TBL] [Abstract][Full Text] [Related]
8. Secreted gingipains from Porphyromonas gingivalis increase permeability in human cerebral microvascular endothelial cells through intracellular degradation of tight junction proteins.
Nonaka S; Kadowaki T; Nakanishi H
Neurochem Int; 2022 Mar; 154():105282. PubMed ID: 35032577
[TBL] [Abstract][Full Text] [Related]
9. Gingipains may be one of the key virulence factors of Porphyromonas gingivalis to impair cognition and enhance blood-brain barrier permeability: An animal study.
Li F; Ma C; Lei S; Pan Y; Lin L; Pan C; Li Q; Geng F; Min D; Tang X
J Clin Periodontol; 2024 Jul; 51(7):818-839. PubMed ID: 38414291
[TBL] [Abstract][Full Text] [Related]
10. Effects of Porphyromonas gingivalis and Its Underlying Mechanisms on Alzheimer-Like Tau Hyperphosphorylation in Sprague-Dawley Rats.
Tang Z; Liang D; Cheng M; Su X; Liu R; Zhang Y; Wu H
J Mol Neurosci; 2021 Jan; 71(1):89-100. PubMed ID: 32557144
[TBL] [Abstract][Full Text] [Related]
11. Porphyromonas gingivalis.
Reyes L
Trends Microbiol; 2021 Apr; 29(4):376-377. PubMed ID: 33546976
[No Abstract] [Full Text] [Related]
12. Treatment of Porphyromonas gulae infection and downstream pathology in the aged dog by lysine-gingipain inhibitor COR388.
Arastu-Kapur S; Nguyen M; Raha D; Ermini F; Haditsch U; Araujo J; De Lannoy IAM; Ryder MI; Dominy SS; Lynch C; Holsinger LJ
Pharmacol Res Perspect; 2020 Feb; 8(1):e00562. PubMed ID: 31999052
[TBL] [Abstract][Full Text] [Related]
13. Porphyromonas gingivalis outer membrane vesicles in cerebral ventricles activate microglia in mice.
Yoshida K; Yoshida K; Seyama M; Hiroshima Y; Mekata M; Fujiwara N; Kudo Y; Ozaki K
Oral Dis; 2023 Nov; 29(8):3688-3697. PubMed ID: 36266256
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of the phosphatidylinositol 3-kinase/Akt signaling pathway by Porphyromonas gingivalis gingipains RgpA, RgpB, and Kgp.
Nakayama M; Inoue T; Naito M; Nakayama K; Ohara N
J Biol Chem; 2015 Feb; 290(8):5190-5202. PubMed ID: 25564612
[TBL] [Abstract][Full Text] [Related]
15. Potential Role of Phosphoglycerol Dihydroceramide Produced by Periodontal Pathogen
Yamada C; Akkaoui J; Ho A; Duarte C; Deth R; Kawai T; Nichols F; Lakshmana MK; Movila A
Front Immunol; 2020; 11():591571. PubMed ID: 33329577
[TBL] [Abstract][Full Text] [Related]
16. Identification and Modification of
Hirai K; Yamaguchi-Tomikawa T; Eguchi T; Maeda H; Takashiba S
Front Immunol; 2020; 11():1017. PubMed ID: 32582160
[TBL] [Abstract][Full Text] [Related]
17. Enzymatic Characteristics and Activities of Gingipains from Porphyromonas gingivalis.
Kadowaki T
Methods Mol Biol; 2021; 2210():97-112. PubMed ID: 32815131
[TBL] [Abstract][Full Text] [Related]
18. Gingipains: Critical Factors in the Development of Aspiration Pneumonia Caused by Porphyromonas gingivalis.
Benedyk M; Mydel PM; Delaleu N; Płaza K; Gawron K; Milewska A; Maresz K; Koziel J; Pyrc K; Potempa J
J Innate Immun; 2016; 8(2):185-98. PubMed ID: 26613585
[TBL] [Abstract][Full Text] [Related]
19. Role of gingipains R in the pathogenesis of Porphyromonas gingivalis-mediated periodontal disease.
Genco CA; Potempa J; Mikolajczyk-Pawlinska J; Travis J
Clin Infect Dis; 1999 Mar; 28(3):456-65. PubMed ID: 10194062
[TBL] [Abstract][Full Text] [Related]
20. Gingipain-dependent augmentation by Porphyromonas gingivalis of phagocytosis of Tannerella forsythia.
Jung YJ; Jun HK; Choi BK
Mol Oral Microbiol; 2016 Dec; 31(6):457-471. PubMed ID: 26434368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
